Novel Clotrimazole Analogs As Blockers Of Intermediate Conductance Kca Channels

Tech ID: 30195 / UC Case 2000-074-0

Full Description

Organ transplants, including liver, heart, kidney, lung and pancreas, are now a routine procedure in many parts of the world. The outcomes of these transplants have improved with the refinement of the procedures but autoimmune rejection of organ transplants remains a major problem. T-lymphocytes play a key role in the immune response but current t-cell inhibiting drugs are toxic, limiting their use.

Researchers at the University of California, Davis, have developed a method compromising of triarylmethane compounds for the immunosuppressive treatment of autoimmune disorders, graft rejection, and graft or host disease. This method utilizes therapeutically effective amounts of certain substituted triarylmethane compounds administered to patients. This results in selectively inhibited lymphocytes without concomitant inhibition of P450-dependent enzyme systems. Thus, an immunosuppressive and anti-inflammatory response can be created while bypassing the usual problem of organ/graft rejection and graft or host disease associated with transplants.

 

Abstract

Researchers at the University of California, Davis, have developed a method for preparing therapeutically effective amounts of triarylmethane compounds for immunosuppressive treatment of autoimmune disorders, graft rejection, and graft or host disease.

Applications

·        Pharmaceuticals

·       Therapeutics

Features/Benefits

Immunosuppressive treatment of autoimmune disorders

Creates an anti-inflammatory response

Minimizes organ/graft rejection and graft or host disease

 

 

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 7,235,577 06/26/2007 2000-074
 

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Inventors

  • Cahalan, Michael D.
  • Chandy, George K.
  • Miller, Mark J.
  • Rauer, Heiko J.
  • Wulff, Heike

Other Information

Keywords

T-lymphocyte, triarylmethane compounds, immunosuppressive, organ transplants, graft rejection, autoimmune, anti-inflammatory

Categorized As